| The bone marrow microenvironment at single-cell resolution AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ... Nature 569 (7755), 222-228, 2019 | 737 | 2019 |
| Nuclear pores promote lethal prostate cancer by increasing POM121-driven E2F1, MYC, and AR nuclear import V Rodriguez-Bravo, R Pippa, WM Song, M Carceles-Cordon, ... Cell 174 (5), 1200-1215. e20, 2018 | 112 | 2018 |
| Candida albicans β-Glucan Exposure Is Controlled by the Fungal CEK1-Mediated Mitogen-Activated Protein Kinase Pathway That Modulates Immune Responses … M Galán-Díez, DM Arana, D Serrano-Gómez, L Kremer, JM Casasnovas, ... Infection and immunity 78 (4), 1426-1436, 2010 | 109 | 2010 |
| Detection of Bacteriophage-Infected Cells of Lactococcus lactis by Using Flow Cytometry O Michelsen, A Cuesta-Dominguez, B Albrechtsen, PR Jensen Applied and environmental microbiology 73 (23), 7575-7581, 2007 | 49 | 2007 |
| The bone marrow microenvironment in health and myeloid malignancy M Galán-Díez, Á Cuesta-Domínguez, S Kousteni Cold Spring Harbor perspectives in medicine 8 (7), a031328, 2018 | 47 | 2018 |
| HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements GR Young, SN Terry, L Manganaro, A Cuesta-Dominguez, G Deikus, ... Journal of virology 92 (1), 10.1128/jvi. 01507-17, 2018 | 37 | 2018 |
| Transforming and tumorigenic activity of JAK2 by fusion to BCR: molecular mechanisms of action of a novel BCR-JAK2 tyrosine-kinase Á Cuesta-Domínguez, M Ortega, C Ormazábal, M Santos-Roncero, ... PLoS One 7 (2), e32451, 2012 | 37 | 2012 |
| Expression of HERV-K108 envelope interferes with HIV-1 production SN Terry, L Manganaro, A Cuesta-Dominguez, D Brinzevich, V Simon, ... Virology 509, 52-59, 2017 | 28 | 2017 |
| BCR–JAK2 drives a myeloproliferative neoplasm in transplanted mice Á Cuesta‐Domínguez, D León‐Rico, L Álvarez, B Díez, I Bodega‐Mayor, ... The Journal of Pathology 236 (2), 219-228, 2015 | 8 | 2015 |
| Candida albicans beta-glucan exposure is controlled by the fungal CEK1-mediated MAPK pathway modulating immune responses triggered through Dectin-1 M Galan-Diez, DM Arana, D Serrano-Gomez, L Kremer, JM Casasnovas, ... Infect Immun 78, 1426-1436, 2010 | 4 | 2010 |
| Serum Amyloid A1 (SAA1) Secreted By the Stromal Microenvironment Drives Malignant Clonal Proliferation in Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) B Chernak, M Galan-Diez, AM Ali, A Cuesta-Dominguez, Z Chen, ... Blood 142, 4118, 2023 | | 2023 |
| 3061–STROMAL CELL-TRIGGERED DOWNREGULATION OF THE NUCLEOPORIN (NUP) FAMILY DRIVES TRANSFORMATION OF MYELODYSPLASIA TO ACUTE MYELOID LEUKEMIA A Cuesta-Dominguez, I Mosialou, M Galan-Diez, A Ali, D Kotini, ... Experimental Hematology 111, S75, 2022 | | 2022 |
| Stromal cell-guided transformation of MDS to AML A Cuesta-Dominguez, I Mosialou, A Ali, J Zhao, M Galan-Diez, ... JOURNAL OF BONE AND MINERAL RESEARCH 35, 3-3, 2020 | | 2020 |
| Activation of beta-catenin signaling in mature osteoblasts versus osteoblast progenitors defines a transcriptional and mutational profile for the transformation of MDS to AML A Cuesta-Dominguez, I Mosialou, J Zhao, A Yoshimi, K Panitsas, ... JOURNAL OF BONE AND MINERAL RESEARCH 33, 71-71, 2018 | | 2018 |
| BCR-JAK2 gene fusion drives a myeloproliferative neoplasm in transplanted mice A Cuesta-Dominguez, M Ortega, D Leon-Rico, M Santos-Roncero, ... HUMAN GENE THERAPY 24 (12), A160-A161, 2013 | | 2013 |
| Caracterización de la capacidad oncogénica de la proteína quimérica BCR-JAK2 AC Domínguez Universidad Autónoma de Madrid, 2013 | | 2013 |
| Caracterización de la capacidad oncogénica de la proteína quimérica BCR-JAK2 A Cuesta Domínguez Caracterización de la capacidad oncogénica de la proteína quimérica BCR-JAK2, 2013 | | 2013 |
| Transforming and Tumorogenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosin-Kinase. A Cuesta-Domínguez, M Ortega, C Ormazabal, M Santos-Roncero, ... Blood, The Journal of the American Society of Hematology 114 (22), 4683-4683, 2009 | | 2009 |
Marta Galan-DiezRegeneron Pharmaceuticals Inc / Columbia UniversityVerified email at cumc.columbia.edu
